BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15207507)

  • 1. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
    Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
    Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes tell lymphatics to sprout or not.
    Folkman J; Kaipainen A
    Nat Immunol; 2004 Jan; 5(1):11-2. PubMed ID: 14699399
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphangiogenesis].
    Hosono K; Majima M
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):290-1. PubMed ID: 23665561
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of lymphangiogenic factors in tumor metastasis.
    He Y; Karpanen T; Alitalo K
    Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenic growth factors as markers of tumor metastasis.
    Stacker SA; Williams RA; Achen MG
    APMIS; 2004; 112(7-8):539-49. PubMed ID: 15563315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of lymphangiogenesis.
    Takahashi M; Yoshimoto T; Kubo H
    Int J Hematol; 2004 Jul; 80(1):29-34. PubMed ID: 15293565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphangiogenesis and tumor progression].
    Vittet D; Feige JJ
    Bull Cancer; 2007 Oct; 94(10):881-6. PubMed ID: 17964982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
    Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
    Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted treatment for lymphedema and lymphatic metastasis.
    Tervala T; Suominen E; Saaristo A
    Ann N Y Acad Sci; 2008; 1131():215-24. PubMed ID: 18519974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sox18 induces development of the lymphatic vasculature in mice.
    François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
    Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the molecular control of the lymphatic vascular system and its role in disease.
    Cueni LN; Detmar M
    J Invest Dermatol; 2006 Oct; 126(10):2167-77. PubMed ID: 16983326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A system for quantifying the patterning of the lymphatic vasculature.
    Shayan R; Karnezis T; Tsantikos E; Williams SP; Runting AS; Ashton MW; Achen MG; Hibbs ML; Stacker SA
    Growth Factors; 2007 Dec; 25(6):417-25. PubMed ID: 18365872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired lymphangiogenesis due to excess vascular endothelial growth factor-D/Flt-4 signalling in the skin of patients with systemic sclerosis.
    Honda N; Jinnin M; Kajihara I; Makino T; Fukushima S; Ihn H
    Br J Dermatol; 2010 Oct; 163(4):776-80. PubMed ID: 20491763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of lymphatic development].
    Kubo H
    Seikagaku; 2004 Sep; 76(9):1210-6. PubMed ID: 15524110
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphangiogenesis in development and human disease.
    Alitalo K; Tammela T; Petrova TV
    Nature; 2005 Dec; 438(7070):946-53. PubMed ID: 16355212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
    Baldwin ME; Halford MM; Roufail S; Williams RA; Hibbs ML; Grail D; Kubo H; Stacker SA; Achen MG
    Mol Cell Biol; 2005 Mar; 25(6):2441-9. PubMed ID: 15743836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.